The study included 1,293 participants with Afib diagnosed before 66 years of age who underwent whole-genome sequencing.
All were enrolled in the study from November 23, 1999, to June 2, 2015, and averaged 56 years old when the study began.
Researchers found rare genetic variants in 10 percent of them.
During the study, 17 percent of participants died in the next 10 years on average. Mortality among patients with the most prevalent genes with disease-associated variants was 26 percent.
“The findings suggest that rare variants in cardiomyopathy and arrhythmia genes may be associated with increased risk of mortality among patients with early-onset AF, especially those diagnosed at a younger age,” the study authors
They emphasized that genetic testing may offer important information about Afib risk for patients diagnosed with EOAF, especially at younger ages.
“Genetic testing should not be performed in all patients with atrial fibrillation,” David S. Park, MD, PhD, cardiac electrophysiologist and assistant professor of medicine at NYU Langone’s Heart Rhythm Center, told Healthline.
However, he added that it could be considered in patients diagnosed with Afib at a young age or who have a family history of early-onset atrial fibrillation (EOAF) and associated cardiomyopathy, sudden death, or early pacemaker implantation.
“This study demonstrates that in younger patients (less than 66 years old) presenting with atrial fibrillation,” said Park. “A rare genetic variant that is considered pathogenic or likely pathogenic was found in 10 percent of the study population.”
He pointed out the condition is “exceedingly common” and best thought of as part of the natural aging process.
“Only one percent of 50 year-olds have it, but 30 percent of 70 year-olds have Afib,” continued Yamamoto. “For most people, it is largely asymptomatic for a long time.”
He explained that two major factors that lead to Afib in older people are higher blood pressure and a natural decline in the heart’s “tempo,” which are inevitable with age.
This procedure uses radiofrequency waves and special tools to identify one or more areas within the heart from which the heart rhythm abnormality originates.
“There are medications that can be used to prevent atrial fibrillation and others that slow the heartbeat toward a more normal rate,” he added. “Blood thinning medications are particularly important to reduce the risk of a stroke.”
They include avoiding excessive caffeine consumption, controlling blood pressure with either lifestyle changes or medication, and treating underlying sleep apnea.
“Other lifestyle changes include optimizing micronutrients such as magnesium which also play an important role in heart rhythm disturbances,” he said.
“Learning good stress management techniques will also help with overproduction of ‘stress hormones’ that can result in atrial fibrillation,” he continued.
He said while there is a greater risk with specific gene variants, in most cases, it’s lifestyle factors that determine if those genes are expressed.
“Understanding the genetic predisposition for any condition, including atrial fibrillation, is very helpful,” said Davis. “However, having a particular gene itself does not relegate a patient to having a particular condition.”
Davis pointed out that lifestyle medications and environmental factors can affect how your genes function, a process called
“It’s very important to understand these epigenetic modifiers that can help influence the expression of genetic variants,” he said.
Researchers have discovered certain genes strongly associated with a diagnosis of early-onset atrial fibrillation – a potentially fatal condition.
Experts say being screened for these genes may benefit some people, mostly those with a strong family history or who have already been diagnosed with Afib at a young age.
They also say that lifestyle can significantly reduce the risk of developing this condition in people who have these genes.